Second Sight Medical Products

Second Sight Medical Products, Inc., located in Sylmar, California, is a privately held company founded in 1998 by Mr. Alfred Mann, Dr. Sam Williams and Gunnar Bjorg with the goal of creating a retinal prosthesis to provide sight to subjects blinded from outer retinal degenerations, such as retinitis pigmentosa. Second Sight currently employs over 85 employees and has a European office in Lausanne, Switzerland.

The first clinical trial (Argus I) began in 2002 (6 subjects in total). With the experience gained from the Argus I trial, and further technological developments, a second generation device was created – the Argus II. For this device, a two-patient pilot study was initiated in Mexico in 2006, followed by a 30-patient trial in 10 centers across Europe and the United States.

Company Growth (employees)
Type
Public
HQ
Los Angeles, US
Founded
1998
Size (employees)
110 (est)-6%
Second Sight Medical Products was founded in 1998 and is headquartered in Los Angeles, US

Second Sight Medical Products Office Locations

Second Sight Medical Products has an office in Los Angeles
Los Angeles, US (HQ)
12477 San Fernando Rd

Second Sight Medical Products Financials and Metrics

Second Sight Medical Products Financials

Second Sight Medical Products's revenue was reported to be $4 m in FY, 2016
USD

Revenue (Q3, 2017)

1.6 m

Gross profit (Q3, 2017)

609 k

Gross profit margin (Q3, 2017), %

38%

Net income (Q3, 2017)

(6.7 m)

EBIT (Q3, 2017)

(6.7 m)

Market capitalization (13-Nov-2017)

68.2 m

Cash (30-Sep-2017)

639 k
Second Sight Medical Products's current market capitalization is $68.2 m.
USDFY, 2015FY, 2016

Revenue

9 m4 m

Revenue growth, %

(55%)

Cost of goods sold

5.3 m10.1 m

Gross profit

3.7 m(6.1 m)
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.7 m2.7 m2.2 m1.1 k1 m1.2 m1 m2.2 m1.6 m

Cost of goods sold

1.3 m1.6 m757.1 k9123.2 m2.6 m1.1 m1.1 m1 m

Gross profit

404.3 k1.1 m1.5 m141(2.2 m)(1.4 m)(118 k)1.1 m609 k

Gross profit Margin, %

24%41%66%13%(213%)(122%)(12%)50%38%
USDFY, 2015FY, 2016

Cash

239 k539 k

Accounts Receivable

1.5 m274 k

Inventories

1.1 m717 k

Current Assets

26.8 m15.3 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

652.3 k407.4 k268.7 k459184 k277 k266 k763 k639 k

Accounts Receivable

1.3 m1.2 m1.3 m822677 k447 k782 k926 k668 k

Inventories

6.4 m6.8 m8.1 m9.1 k7.4 m5.8 m3.1 m3.1 m462 k

Current Assets

38.4 m35.7 m31.9 m21.1 k32.5 m24.7 m28.6 m22.8 m17.7 m
    USDFY, 2015FY, 2016

    Net Income

    (20 m)(33.2 m)

    Depreciation and Amortization

    335 k432 k

    Accounts Receivable

    (793 k)955 k

    Inventories

    (2.5 m)10 k
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    (5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.5 m)(14.4 m)(6.7 m)

    Accounts Receivable

    1.3 m1.2 m1.3 m822677 k447 k(454 k)(704 k)668 k

    Inventories

    1 m1.9 m462 k

    Accounts Payable

    414.4 k330.4 k544.4 k707671 k694 k(269 k)(528 k)826 k
      Y, 2017

      Financial Leverage

      1.5 x
      Show all financial metrics

      Second Sight Medical Products Operating Metrics

      FY, 2016

      Patents Pending

      126

      Patents Issued

      381
      Show all operating metrics

      Second Sight Medical Products Market Value History

      Second Sight Medical Products's Web-traffic and Trends

      Second Sight Medical Products Online and Social Media Presence

      Second Sight Medical Products Company Life and Culture

      You may also be interested in